Abstract
Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases due to the roles of MSCs in regeneration, fibrosis inhibition and immune regulation. However, the mechanisms are still not completely understood. Despite the significant efficacy of MSC therapy in animal models and preliminary clinical trials, issues remain. The efficacy and safety of MSC-based therapy in the treatment of liver diseases remains a challenging issue that requires more investigation. This article reviews recent studies on the mechanisms of MSCs in liver diseases and the associated challenges and suggests potential future applications.
Author supplied keywords
Cite
CITATION STYLE
Yang, Y., Zhao, Y., Zhang, L., Zhang, F., & Li, L. (2021, May 31). The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Frontiers in Medicine. Frontiers Media S.A. https://doi.org/10.3389/fmed.2021.655268
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.